- Home
- EWTX vs AAP Comparison
EWTX vs AAP Comparison
Compare EWTX & AAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- AAP
- Stock Information
- Founded
- EWTX 2017
- AAP 1929
- Country
- EWTX United States
- AAP United States
- Employees
- EWTX N/A
- AAP N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- AAP Auto & Home Supply Stores
- Sector
- EWTX Health Care
- AAP Consumer Discretionary
- Exchange
- EWTX Nasdaq
- AAP Nasdaq
- Market Cap
- EWTX 2.3B
- AAP 2.0B
- IPO Year
- EWTX 2021
- AAP N/A
- Fundamental
- Price
- EWTX $20.13
- AAP $39.05
- Analyst Decision
- EWTX Buy
- AAP Hold
- Analyst Count
- EWTX 8
- AAP 16
- Target Price
- EWTX $45.38
- AAP $44.38
- AVG Volume (30 Days)
- EWTX 1.5M
- AAP 2.4M
- Earning Date
- EWTX 03-03-2025
- AAP 05-28-2025
- Dividend Yield
- EWTX N/A
- AAP 2.56%
- EPS Growth
- EWTX N/A
- AAP N/A
- EPS
- EWTX N/A
- AAP N/A
- Revenue
- EWTX N/A
- AAP $9,094,327,000.00
- Revenue This Year
- EWTX N/A
- AAP N/A
- Revenue Next Year
- EWTX N/A
- AAP $1.24
- P/E Ratio
- EWTX N/A
- AAP N/A
- Revenue Growth
- EWTX N/A
- AAP N/A
- 52 Week Low
- EWTX $14.90
- AAP $33.08
- 52 Week High
- EWTX $38.12
- AAP $85.58
- Technical
- Relative Strength Index (RSI)
- EWTX 28.86
- AAP 49.74
- Support Level
- EWTX $21.58
- AAP $38.25
- Resistance Level
- EWTX $25.36
- AAP $41.67
- Average True Range (ATR)
- EWTX 1.99
- AAP 1.60
- MACD
- EWTX -0.38
- AAP 0.55
- Stochastic Oscillator
- EWTX 2.67
- AAP 51.12
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About AAP Advance Auto Parts Inc.
Advance Auto Parts Inc is an automotive aftermarket parts provider in North America, serving both professional installers (professional) and do it yourself (DIY) customers, as well as independently owned operators. The Company's stores and branches offer a range selection of brand names, original equipment manufacturer (OEM) and owned brand automotive replacement parts, accessories, batteries and maintenance items for domestic and imported cars, vans, sport utility vehicles and light and heavy-duty trucks.eds.